Revenue Recognition (Tables)

3 Months Ended

Apr. 01, 2023

Revenue from Contract with Customer [Abstract]

Summary of Disaggregation of Revenue

The following is a summary of our net sales by category(1) (in millions):

	Three Months Ended
	April 1, 2023		April 2, 2022
CSCA
Upper Respiratory	$	154.3	$	152.8
Nutrition	139.9		127.2
Digestive Health	124.2		118.6
Pain and Sleep-Aids	103.5		102.9
Oral Care	84.4		70.4
Healthy Lifestyle	73.4		67.6
Skin Care	52.3		40.9
Women's Health	11.9		8.2
Vitamins, Minerals, and Supplements ("VMS")	4.0		7.7
Other CSCA(2)	15.8		13.7
Total CSCA	763.7		710.0
CSCI
Upper Respiratory	84.8		66.5
Skin Care	83.4		73.9
Healthy Lifestyle	66.4		58.9
Pain and Sleep-Aids	49.9		54.0
VMS	47.8		49.5
Women's Health	29.1		13.7
Oral Care	29.1		28.9
Digestive Health	8.8		9.2
Other CSCI(3)	18.8		9.9
Total CSCI	418.1		364.5
Total net sales	$	1,181.7	$	1,074.5

(1) We updated our global reporting product categories as a result of our product portfolio reconfiguration. These product categories have been adjusted retroactively to reflect the changes and have no impact on historical financial position, results of operations, or cash flows.

(2) Consists primarily of product sales and royalty income related to supply and distribution agreements and other miscellaneous or otherwise uncategorized product lines and markets, none of which is greater than 10% of the segment net sales.

(3) Consists primarily of our rare diseases business and other miscellaneous or otherwise uncategorized product lines, none of which is greater

than 10% of the segment net sales.

We generated net sales in the following geographic locations(1) (in millions):

	Three Months Ended
	April 1, 2023		April 2, 2022
U.S.	$	750.0	$	683.1
Europe(2)	407.3		351.7
All other countries(3)	24.4		39.7
Total net sales	$	1,181.7	$	1,074.5

(1) The net sales by geography are derived from the location of the entity that sells to a third party.

(2) Includes Ireland net sales of $7.3 million and $6.6 million for the three months ended April 1, 2023 and April 2, 2022, respectively.

(3) Includes net sales generated primarily in Australia and Canada.

Summary of Contract with Customer Balances

The following table provides information about contract assets from contracts with customers (in millions):

	Balance Sheet Location	April 1, 2023		December 31, 2022
Short-term contract assets	Prepaid expenses and other current assets	$	31.7	$	41.5